🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7989501

Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964559

MVL, an antiviral protein from a cyanobacterium

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7939639

Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathol

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928096

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related c

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928079

Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919301

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of reco

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915036

Compositions comprising T cell receptors and methods of use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842798

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7785565

Metal chelators and methods of their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7641909

Avirulent, immunogenic flavivirus chimeras

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7619057

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511032

Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related th

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7504430

Maleiimide anti-tumor phosphatase inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501501

MHC-Class II restricted melanoma antigens and their use in therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498336

Deazaflavin compounds and methods of use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7459536

HGF-SF monoclonal antibody combinations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7456222

Anti tubercular drug: compositions and methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427671

Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7417136

Nucleic acid vaccines for prevention of flavivirus infection

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7341726

Modified HCV peptide immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7319091

Human derived monocyte attracting purified protein product useful in a method of treating

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244558

Production of novel Newcastle disease virus strains from cDNAs and improved live attenuate

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7232671

Pertussis toxin gene: cloning and expression of protective antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7226602

Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted